versr2 warf2
Name
warf1
Label
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1)
Description

Participant taking ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE within two weeks of the SHHS1 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
  • 8: Don't know
Type
choices
Tags
acute coronary syndrome deep-vein thrombosis DVT pulmonary embolism WARF1
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs SHHS Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total 5,804 - - -
No 5,653 - - -
Yes 133 - - -
Don't know - - - -
Unknown 18 - - -
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Age at SHHS1
Visit 1
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 342 1,017 1,769 1,617 955 104 5,804
No 333 1,011 1,752 1,558 899 100 5,653
Yes 3 2 14 57 53 4 133
Don't know - - - - - - -
Unknown 6 4 3 2 3 - 18
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Gender
Visit 1
Male Female Total
Total 2,765 3,039 5,804
No 2,669 2,984 5,653
Yes 85 48 133
Don't know - - -
Unknown 11 7 18
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Race
Visit 1
White Black Other Total
Total 4,907 515 382 5,804
No 4,776 503 374 5,653
Yes 121 7 5 133
Don't know - - - -
Unknown 10 5 3 18